Navigation Links
PriceSpective Appoints Colasante as a Vice President and Murdoch as a Director

LONDON, Sept. 8 /PRNewswire/ -- PriceSpective, a value strategy consultancy that provides pricing and reimbursement services to pharmaceutical and biotechnology companies, is pleased to announce that it has hired two senior experts for its UK office. Walter Colasante, as a Vice President, and Sophie Murdoch, as a Director, will help further strengthen PriceSpective's pricing and reimbursement expertise and expand its current offerings.

Colasante, who brings 20 years experience in healthcare, will contribute to PriceSpective's real world pricing and reimbursement knowledge and client guidance, and will enhance PriceSpective's forecasting and portfolio and risk management services. Reflective of PriceSpective's promise of active senior level project involvement, Colasante will be an immediate resource for clients.

Expanding PriceSpective's commercial and device expertise, Murdoch brings 12 years of pharmaceutical experience. Murdoch will play a key role in developing strategic guidance for clients that synchronizes pricing and commercial goals.

"With ever-increasing pressure on drug pricing and debates over healthcare reforms across the globe," said CEO Steve Slovick, "we are delighted to bring on two, outstanding senior-level experts whose unique and diverse experiences will ensure the continuation of high quality services to our clients in a dynamic marketplace. Meanwhile, UK-based partner Keiron Sparrowhawk said, "Walter and Sophie will be invaluable in the continued growth and expansion of PriceSpective, enabling us to further meet our clients' needs."

Previously, Colasante was the founder and Managing Director of Freelance Heath Services, which specialised in pharmaceutical forecasting, business analysis and intelligence, market access planning and epidemiology. Colasante's previous consulting experience includes serving as a General Manager at The Mattson Jack Group and as a Senior Engagement Director at IMS. Colasante has also worked in clinical development for Novartis, Allergan and BMS.

Previously, Murdoch was an Associate Director at BMS, where she was responsible for developing the EMEA commercialization strategy for IXEMPRA. Before BMS, Murdoch was a Global Associate Director Hydrofiber Franchise at ConvaTec, a Marketing Manager at SSL International, and an International Product Manager at Smith & Nephew.

About PriceSpective

PriceSpective is a management consulting firm specializing in innovative strategies to identify, capture and communicate value for companies in the biopharmaceutical arena. We are uniquely positioned to deliver expert guidance in integrated global pricing, reimbursement and market access strategy due to our depth of experience and the active engagement of our senior leadership.

Over the last year, PriceSpective has climbed from position #413 on Inc 500's list of 'Fastest Growing Private Companies in America' to # 174. PriceSpective has offices in Los Angeles, Philadelphia and London and has a global staff of 49 professionals.

SOURCE PriceSpective
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. PriceSpective Continues Global Expansion With New San Diego Office
2. iPierian Appoints Dr. Matthew J. Plunkett as Chief Financial Officer
3. Affitech Appoints Dr Robert Burns as CEO and Dr Alexander Duncan as SVP Research & Development
4. ERT Appoints New Associate Director of Business Development - Japan
5. NeurogesX Appoints New Board Director and Audit Committee Chairman
6. Orexigen(R) Therapeutics Appoints Mark Booth Chief Commercial Officer
7. Eiger BioPharmaceuticals Appoints Paul Truex to Board of Directors
8. Nucleix Appoints Meirav Chovav Vice President of Strategic Affairs and to the Board of Directors
9. Spectral appoints new board member
10. Cellular Dynamics International Appoints Leroy Hood, M.D., Ph.D., and George Church, Ph.D., to its Scientific Advisory Board
11. China Sky One Medical, Inc. Appoints New Independent Director
Post Your Comments:
(Date:11/30/2015)... , Nov. 30, 2015  AbbVie, is introducing ... focuses on a daily routine for managing the life-long ... medication can affect the way the body absorbs it ... their a daily routine are important. The goal of ... patients better manage their hypothyroidism by establishing a daily ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... integration with MarkLogic, the Enterprise NoSQL database platform provider, creating a seamless ... , Smartlogic’s Content Intelligence capabilities provide a robust set of semantic tools ...
(Date:11/27/2015)... , Nov. 27, 2015 /PRNewswire/--  Mallinckrodt plc (NYSE: ... today that it has closed the sale of its ... Guerbet (GBT- NYSE Euronext) in a transaction valued at ... manufacturing facilities and a total of approximately 1,000 employees ... St. Louis area. This entire ...
(Date:11/26/2015)... 26, 2015 ... Accutest Research Laboratories, a leading independent ... (CRO), has formed a strategic partnership ... Temple Health for joint work on ... ) , --> ...
Breaking Biology Technology:
(Date:11/10/2015)... YORK , Nov. 10, 2015 ... to behavioral biometrics that helps to identify and ... fraud. Signature is considered as the secure and ... the identification of a particular individual because each ... more accurate results especially when dynamic signature of ...
(Date:10/29/2015)...   MedNet Solutions , an innovative SaaS-based eClinical ... research, is pleased to announce that it has been ... one of only three finalists for a 2015 ... Growing" category. The Tekne Awards honor Minnesota ... innovation and leadership. iMedNet™ eClinical ...
(Date:10/29/2015)... Connecticut , October 29, 2015 ... a biometric authentication company focused on the growing ... smart wallet announces that StackCommerce, a leading marketplace ... be featuring the Wocket® smart wallet on StackSocial ... NXTD ) ("NXT-ID" or the "Company"), a biometric ...
Breaking Biology News(10 mins):